相关实验视频

Updated: Sep 8, 2025

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

Published on: June 14, 2021

用Mn Porphyrin,MnTnBuOE-2-PyP⁵⁺ (BMX- 001) 抑制帕克利塔塞尔诱导的神经病变和卵巢瘤的生长

Ivan Spasojevic¹, Zhiqing Huang², Welida Tamires Alves da Silva¹

¹Department of Medicine-Division of Oncology and Duke Cancer Institute PK/PD Core Laboratory, Duke University School of Medicine, Durham 27710, North Carolina, USA.

Oxidative medicine and cellular longevity

|September 3, 2025

概括

像BMX-001这样的抗氧化色素有望防止化疗引起的神经病变,并抑制卵巢癌的生长. 这种双重作用有可能改善癌症治疗,并减少副作用.

科学领域:

转毒生物学和癌症治疗
药理学和毒理学
神经科学和瘤学

背景情况:

通过调节氧化还原信号通路,保护正常组织并抑制瘤生长.
模仿超氧化脱酶的 MnPs 正在作为影响细胞氧化还原状态的治疗药物开发.
BMX-001 (MnTnBuOE-2-PyP5+) 是一种临床上先进的甲,用于研究中枢神经系统损伤.

研究的目的:

评估BMX- 001在小鼠中缓解帕克利塔塞尔 (PTX) 诱导的神经病变的疗效.
评估BMX-001作为单一药物对高度卵巢癌 (CAOV2) 的抗癌作用.
探索BMX-001在妇科癌症和一般化疗诱导的神经病的治疗潜力.

主要方法:

雌性CD-1小鼠在每日和临床相关的剂量方案中接受BMX- 001治疗.
通过机械和热刺激测试来评估神经病变,并通过旋杆和体重监测总体状况.
在CAOV2卵巢癌的皮下异种移植模型中评估了抗癌效果.

主要成果:

BMX- 001显著抑制了帕克利塔塞尔诱导的周围神经病变和神经炎症.
BMX- 001对CAOV2卵巢癌具有强大的抗癌作用,与帕克利塔塞尔相当.
该研究观察到BMX- 001作为单一药物的显著神经保护和抗癌活性.

结论:

在治疗化疗诱导的神经病变和卵巢癌方面,BMX- 001具有显著的治疗潜力.
BMX- 001的双重疗效表明其在减少化疗副作用和增强癌症治疗中的有用性.
BMX- 001可能对各种神经病引起的化疗药物有益.

关键词:

其他:甲 TnBuOE-2-PyP5+ 的使用模仿SOD的方法细胞和小鼠瘤研究小鼠神经病变模型卵巢高度血清性CAOV2癌症

更多相关视频

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...